Related Experiment Video
Updated: May 9, 2026

Early Weight-Bearing Rehabilitation Protocol After Anterior Cruciate Ligament Reconstruction
Published on: March 1, 2024
Posttraumatic reduction of edema with aquaporin-4 RNA interference improves acute and chronic functional recovery
Andrew M Fukuda1, Arash Adami, Viorela Pop
11] Department of Physiology, Loma Linda University, Loma Linda, California, USA [2] Department of Pediatrics, Loma Linda University Medical Center, Loma Linda, California, USA.
Insights
Targeting aquaporin-4 (AQP4) with small-interfering RNA (siRNA) after traumatic brain injury (TBI) in young rats reduced brain swelling and improved neurological function. This novel therapeutic approach shows promise for mitigating TBI
Area of Science:
- Neuroscience
- Biomedical Engineering
- Molecular Biology
Background:
- Traumatic brain injury (TBI) in children and adolescents leads to significant disability and mortality.
- Edema formation and brain swelling are key neuropathologic consequences of juvenile TBI.
- Aquaporin-4 (AQP4) plays a critical role in the development of brain edema.
Purpose of the Study:
- To investigate the efficacy of inhibiting AQP4 expression using small-interfering RNA (siAQP4) in reducing edema and improving outcomes after juvenile TBI.
- To evaluate the impact of siAQP4 treatment on neuroinflammation, neuronal cell death, and neurological function.
Main Methods:
- Controlled cortical impact was used to induce TBI in postnatal day 17 rats.
- siAQP4 or a control siRNA (siGLO) was injected near the trauma site.
- Magnetic resonance imaging, neurological tests, and immunohistochemistry were employed to assess outcomes.
Main Results:
- siAQP4 treatment led to acute improvements in motor function and long-term enhancements in spatial memory compared to controls.
- These functional improvements correlated with reduced edema, decreased blood-brain barrier disruption, and attenuated neuroinflammation (microglial activation, astrogliosis).
- A 30% reduction in AQP4 expression was observed at the injection site in the treated group.
Conclusions:
- Inhibiting AQP4 expression via siRNA is a viable therapeutic strategy for mitigating neuropathologic sequelae following juvenile TBI.
- This approach effectively reduces edema, neuroinflammation, and neuronal cell death, leading to improved neurological outcomes.
- Targeting AQP4 offers a promising avenue for novel TBI treatments in young populations.
Abstract:
Traumatic brain injury (TBI) is common in young children and adolescents and is associated with long-term disability and mortality. The neuropathologic sequelae that result from juvenile TBI are a complex cascade of events that include edema formation and brain swelling. Brain aquaporin-4 (AQP4) has a key role in edema formation. Thus, development of novel treatments targeting AQP4 to reduce edema could lessen the neuropathologic sequelae. We hypothesized that inhibiting AQP4 expression by injection of small-interfering RNA (siRNA) targeting AQP4 (siAQP4) after juvenile TBI would decrease edema formation, neuroinflammation, neuronal cell death, and improve neurologic outcomes. The siAQP4 or a RNA-induced silencing complex (RISC)-free control siRNA (siGLO) was injected lateral to the trauma site after controlled cortical impact in postnatal day 17 rats. Magnetic resonance imaging, neurologic testing, and immunohistochemistry were performed to assess outcomes. Pups treated with siAQP4 showed acute (3 days after injury) improvements in motor function and in spatial memory at long term (60 days after injury) compared with siGLO-treated animals. These improvements were associated with decreased edema formation, increased microglial activation, decreased blood-brain barrier disruption, reduced astrogliosis and neuronal cell death. The effectiveness of our treatment paradigm was associated with a 30% decrease in AQP4 expression at the injection site.
Related Concept Videos
Aquaporins
Cerebral Edema l: Introduction
Cerebral Edema ll: Pathophysiology
Cytotoxic Edema: Pathophysiology
Pulmonary Edema II: Pathophysiology